Evidence map›Paper›PMID 36004313›Full record

ArticleOpen forum infectious diseases2022

Pathogen Detection by Metagenomic Next-Generation Sequencing During Neutropenic Fever in Patients With Hematological Malignancies.

Eduard Schulz, Silke Grumaz, Stefan Hatzl, Maximilian Gornicec, Thomas Valentin, Bianca Huber-Kraßnitzer, Lisa Kriegl, Barbara Uhl, Alexander Deutsch, Hildegard Greinix and 2 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Eduard SchulzDepartment of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.ORCID https://orcid.org/0000-0002-6672-4592
Silke GrumazNoscendo GmbH, Duisburg, Germany.
Stefan HatzlDepartment of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.
Maximilian GornicecDepartment of Internal Medicine, Division of Infectious Diseases, Medical University of Graz, Graz, Austria.
Thomas ValentinDepartment of Internal Medicine, Division of Infectious Diseases, Medical University of Graz, Graz, Austria.
Bianca Huber-KraßnitzerDepartment of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.
Lisa KrieglDepartment of Internal Medicine, Division of Infectious Diseases, Medical University of Graz, Graz, Austria.
Barbara UhlDepartment of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.
Alexander DeutschDepartment of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.
Hildegard GreinixDepartment of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.
Robert KrauseDepartment of Internal Medicine, Division of Infectious Diseases, Medical University of Graz, Graz, Austria.
Peter NeumeisterDepartment of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.
Medical University of Graz · ATNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Febrile neutropenia (FN) after chemotherapy is a major cause of morbidity during cancer treatment. The performance of metagenomic next-generation sequencing (mNGS) of circulating cell-free deoxyribonucleic acid from plasma may be superior to blood culture (BC) diagnostics for identification of causative pathogens. The aim of this study was to validate mNGS (DISQVER test) for the detection of pathogens in hematologic patients with FN. Methods: We collected paired whole blood specimens from central venous catheter and peripheral vein during FN for BC and mNGS testing. We repeated paired sampling at the earliest after 3 days of fever, which was defined as 1 FN episode. All clinical data were retrospectively reviewed by an infectious disease expert panel. We calculated percent positive agreement (PPA), percent negative agreement (PNA), percent overall agreement (POA), and sensitivity and specificity. Results: We analyzed a total of 98 unselected FN episodes in 61 patients who developed predominantly FN after conditioning therapy for allogeneic ( Conclusions: Pathogen detection by mNGS (DISQVER) during unselected FN episodes shows 2-fold higher sensitivity and a broader pathogen spectrum than BC.

Indexed as

blood culturefebrile neutropeniainfectionmetagenomicstem cell transplantation

Identifiers

PMID36004313
PMCPMC9394763
OpenAlexW4288826405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.